Close
ACHEMA MIDDLE EAST 2026

Anti-Blindness Effort Pioneered by NewYork-Presbyterian/Columbia University Medical Center’s Tele-Ophthalmology Unit

Presbyterian/Columbia University Medical Center (CUMC) recently unveiled a state-of-the-art mobile testing unit in a push to reduce blindness-causing eye diseases across the city. The...

Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation for Omaveloxolone for the Treatment of Malignant Melanoma

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, today announced that the United States Food and Drug Administration (“FDA”) has granted orphan designation to omaveloxolone...

InDex Pharmaceuticals gets new patent granted in Japan

InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod has been granted by the...

NeuroRx awarded FDA Fast Track Designation for first drug regimen targeting suicide in bipolar depression

NeuroRx, a clinical stage biopharma company developing the first oral therapy for Acute Suicidal Ideation and Behavior (ASIB), has been granted Fast Track status by...

2017 Scientist Award For Best New Clinical Laboratory Product received by Agilent

Agilent Technologies Inc. has received a 2017 Scientists' Choice Award for Best New Clinical Laboratory Product: the IQFISH Panel for Lung Cancer. The IQFISH...

Adamas Announces FDA Approval of GOCOVRI as First and Only Medication for the Treatment of Dyskinesia in Parkinson’s Disease Patients

Adamas Pharmaceuticals, Inc. announced that the U.S. FDA has approved GOCOVRI extended release capsules (previously ADS-5102) for treatment of dyskinesia in patients with Parkinson's...

Charter Medical Announces Completion of Major Rebranding Initiative

Charter Medical Ltd., a globally recognized manufacturer of products for the regenerative medicine, blood management, and bioprocessing industries, unveiled a modernized identity this morning...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...